Skip to main content

Neurohormonal Signalling Pathways and the Regulation of Alzheimer β-Amyloid Metabolism Integrating Basic and Clinical Observations for Developing Successful Strategies to Delay, Retard or Prevent Cerebral Amyloidosis in Alzheimer’s Disease

  • Chapter
  • 159 Accesses

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 155))

Abstract

Alzheimer’s disease (AD) is characterized by the intracranial accumulation of the 4-kDa amyloid-β peptide (Aβ), following proteolysis of a ∼ 700-amino acid, integral membrane precursor, the Alzheimer amyloid precursor protein (APP). The best evidence causally linking APP to Alzheimer’s disease has been provided by the discovery of mutations within the APP coding sequence that segregate with disease phenotypes in autosomal dominant forms of familial Alzheimer’s disease (FAD). Though FAD is rare (<10% of all AD), the hallmark features — amyloid plaques, neurofibrillary tangles, synaptic and neuronal loss, neurotransmitter deficits, dementia — are indistinguishable when FAD is compared with typical, common, “non-familial,” or sporadic, AD (SAD). Studies of some clinically relevant mutant APP molecules from FAD families have yielded evidence that APP mutations can lead to enhanced generation or aggregability of Aβ, consistent with a pathogenic role in AD. Other genetic loci for FAD have been discovered which are distinct from the immediate regulatory and coding regions of the APP gene, indicating that defects in molecules other than APP can also specify cerebral amyloidogenesis and FAD. To date, all APP and non-APP FAD mutations can be demonstrated to have the common feature of promoting amyloidogenesis of Aβ.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abraham CR, Selkoe DJ, Potter H (1988) Immunochemical identification of the serine protease inhibitor α 1-antichymotrypsin in the brain amyloid deposits of Alzheimer’s disease. Cell 52:487–501

    Article  PubMed  CAS  Google Scholar 

  • Arendt T, Schindler C, Bruckner MK, Escherich K, Bigl V, Zedlick D, Marcova L (1997) Plastic neuronal remodeling is impaired in patients with Alzheimer’s disease carrying apolipoprotein epsilon 4 allele. J Neurosci 17(2):516–529

    PubMed  CAS  Google Scholar 

  • Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM (1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet 17(3):263–264

    CAS  Google Scholar 

  • Bates SE, Davidson NE, Valverius EM, Freter CE, Dickson RB, Tarn JP, Kudlow JE, Lippman ME, Salomon DS (1988) Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol 2:543–555

    Article  PubMed  CAS  Google Scholar 

  • Berg L, McKeel, DW, Miller JP, Baty J, Morris JC (1993) Neuropathological indexes of Alzheimer’s disease in demented and nondemented persons aged 80 years and older. Arch Neurol 50:349–358

    Article  PubMed  CAS  Google Scholar 

  • Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385(6618):729–733

    Article  PubMed  CAS  Google Scholar 

  • Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG, Sisodia SS (1996) Familial Alzheimer’s disease-linked presenilin 1 variants elevate Abeta1–42/1–40 ratio in vitro and in vivo. Neuron 17(5):1005–1013

    Article  PubMed  CAS  Google Scholar 

  • Borsenberg MW, Pandiella A, Massague J (1993) Activated release of membrane-anchor TGF-α in the absence of cytosol. J Cell Biol 122:95–101

    Article  Google Scholar 

  • Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Colman C, Glabe C (1992) Assembly and aggregation properties of synthetic Alzheimer’s A4/β amyloid peptide analogs. J Biol Chem 267:546–554

    PubMed  CAS  Google Scholar 

  • Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P (1992) Cholinergic agonists and interleukin I regulase processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc Natl Acad Sci USA 89:101175–10078

    Google Scholar 

  • Buxbaum JD, Liu KN, Luio Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273(43):27765–27767

    Article  PubMed  CAS  Google Scholar 

  • Buxbaum JD, Gandy SE, Cicchetti P, Ehrlich ME, Czernik AJ, Fracasso RP, Ramabhadran TV, Unterbeck AJ, Greengard P (1990) Processing of Alzheimer β/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci USA 87:6003–6006

    Article  PubMed  CAS  Google Scholar 

  • Buxbaum JD, Koo EH, Greengard P (1993) Protein phosphorylation inhibits production of Alzheimer amyloid β/A4 peptide. Proc Nati Acad Sci USA 90:9195–9198

    Article  CAS  Google Scholar 

  • Calhoun ME, Wiederhold KH, Abramowski D, Phinney AL, Probst A, Sturchler-Pierrat C, Staufenbiel M, Sommer B, Jucker M (1998) Neuron loss in APP transgenic mice. Nature 395:755–756

    Article  PubMed  CAS  Google Scholar 

  • Caporaso G, Takei K, Gandy S, Matteoli M, Mundigl I, Greengard P, de Camilli P (1994) Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer β/A4 amyloid precursor protein. J Neurosci 14 (5 Pt 2):3122–3138

    PubMed  CAS  Google Scholar 

  • Caporaso GL, Gandy SE, Buxbaum JD, Ramabhadran TV, Greengard P (1992) Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein. Proc Natl Acad Sci USA 89:3055–3059

    Article  PubMed  CAS  Google Scholar 

  • Chang D, Kwan J, Timiras PS (1997) Estrogens influence growth, maturation and amyloid beta-peptide production in neuroblastoma cells and in a beta-APP transfected kidney 293 cell line. Adv Exp Med Biol 429:261–271

    Article  PubMed  CAS  Google Scholar 

  • Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L (1988) Clinico-pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer’s disease. Neurology 38:1682–1687

    Article  PubMed  CAS  Google Scholar 

  • da Cruz e Silva 0, Iverfeldt K, Oltersdorf T, Sinha S, Lieberburg I, Ramabhadran T, Suzuki T, Sisodia S, Gandy S, Greenard P (1993) Regulated cleavage of Alzheimer β-amyloid precursor protein in the absence of the cytoplasmic tail. Neuroscience 57:873–877

    Article  Google Scholar 

  • Danenberg HD, Haring R, Heldman E, Gurwitz D, Ben-Nathan D, Pittel Z, Zuckerman A, Fisher A (1995) Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12M1 cells. Ann NY Acad Sci 774:300–303

    Article  PubMed  CAS  Google Scholar 

  • Danenboerg HD, Haring R, Fisher A, Pittel Z, Gurwitz D, Heldman E (1996) Dehydroepiandrosterone (DHEA) increases production and release of Alzheimer’s amyloid precursor protein. Life Sci 59(19):1651–1657

    Article  Google Scholar 

  • Delaere P, He Y, Fayet G, Duyckaerts C, Hauw JJ (1993) βA4 deposits are constant in the brain of the older old: An immunocytochemical study of 20 French centenarians. Neurobiol Aging 14:191–194

    Article  PubMed  CAS  Google Scholar 

  • Dickson RB, Huff KK, Spencer EM, Lippman ME (1986) Induction of epidermal growth factor-related polypeptides by 17 beta-estradiol in MCF-7 human breast cancer cells. Endocrinology 118:138–142

    Article  PubMed  CAS  Google Scholar 

  • Dickson RB, McManaway ME, Lippman ME (1986) Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res 46:1707–1713

    PubMed  CAS  Google Scholar 

  • Dickson RB, McManaway ME, Lippman ME (1986) Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science 232:1540–1543

    Article  PubMed  CAS  Google Scholar 

  • Drouva SV, Geronne I, Laplante E, Rerat E, Enjalbert A, Kordon C (1990) Estradiol modulates protein kinase C activity in the rat pituitary in vivo and in vitro. Endocrinology 126:536–544

    Article  PubMed  CAS  Google Scholar 

  • Fisher A, Heldman E, Gurwitz D, Haring R, Karton Y, Meshulam H, Pittel Z, Marciano D, Brandeis R, Sadot E, Barg Y, Pinkas-Kramarski R, Vogel Z, Ginzburg I, Treves TA, Verchovsky R, Klimowsky S, Korczyn AD (1996) M1 agonists for the treatment of Alzheimer’s disease: Novel therapeutic properties and clinical update. Ann NY Acad Sci 777:189–196

    Article  PubMed  CAS  Google Scholar 

  • Fukuyama R, Chandrasekaran K, Rapoport SI (1993) Nerve growth factor-induced neuronal differentiation is accompanied by differential induction and localization of the amyloid precursor protein (APP) in PC12 cells and variant PC12S cells. Brain Res Mol Brain Res 17:17–22

    Article  PubMed  CAS  Google Scholar 

  • Gandy S (1999) Neurohormonal signaling pathways and the regulation of Alzheimer β-amyloid precursor metabolism (review). Trends Endocrinol Metab 10:273–279

    Article  PubMed  CAS  Google Scholar 

  • Gandy S, Czernik AJ, Greengard P (1988) Phosphorylation of Alzheimer’s disease amyloid precursor peptide by protein kinase C and Ca+2/calmodulin-dependent protein kinase II. Proc Natl Acad Sci USA 85:6218–6221

    Article  PubMed  CAS  Google Scholar 

  • Gandy S, Greengard P (1992) Amyloidogenesis in Alzheimer’s disease: Some possible therapeutic opportunities. Trends Pharmacol Sci 13:108–113

    Article  PubMed  CAS  Google Scholar 

  • Gandy S, Greengard P (1994) Processing of Aβ-amyloid precursor protein: Cell biology, regulation, and role in Alzheimer’s disease. Intl Rev Neurobiol 36:29–50

    Article  CAS  Google Scholar 

  • Gillespie SL, Golde TE, Younkin SG (1992) Secretory processing of the Alzheimer amyloid β/A4 protein precursor is increased by protein phosphorylation. Biochem Biophys Res Commun 187:1285–1290

    Article  PubMed  CAS  Google Scholar 

  • Gouras GK, Xu H, Jovanovic JN, Buxbaum JD, Wang R, Greengard P, Relkin NR, Gandy S (1998) Generation and regulation of beta-amyloid peptide variants by neurons. J Neurochem 71(5):1920–1925

    Article  PubMed  CAS  Google Scholar 

  • Gridley KE, Green PS, Simpkins JW (1998) A novel, synergistic interaction between 17β-estradiol and glutathione in the protection of neurons against Aβ 25–35-induced toxicity In vitro. Mol Pharmacol 4(5):874–880

    Google Scholar 

  • Haring R, Fisher A, Marciano D, Pittel Z, Kloog Y, Zuckerman A, Eshhar N, Heldman E (1998) Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the ml muscarinic receptor to β-amyloid precursor protein secretion. J Neurochem 71:2094–2103

    Article  PubMed  CAS  Google Scholar 

  • Hung AY, Haass C, Nitsch RM, Qiu WQ, Citron M, Wurtman RJ, Growdon JH, Selkoe DJ (1993) Activation of protein kinase C inhibits cellular production of the amyloid β-protein. J Biol Chem 268:22959–22962

    PubMed  CAS  Google Scholar 

  • Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 12(1):45–53

    Article  Google Scholar 

  • Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE (1994) Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem 269(18):13065–13068

    PubMed  CAS  Google Scholar 

  • Kamel F, Kubajak CL (1988) Gonodal steroid effects on LH response to arachidonic acid and protein kinase C. Am J Physiol 155:314–321

    Google Scholar 

  • Komano HM, Seeger M, Gandy S, Wang GT, Krafft GA, Fuller RS (1998) Involvement of cell surface glycosyl-phosphatidylinositol-linked aspartyl proteases in alpha-secretase-type cleavage and ectodomain solubilization of human Alzheimer beta-amyloid precursor protein in yeast. J Biol Chem 273(48):31648–31651

    Article  PubMed  CAS  Google Scholar 

  • Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ (1996) Sequence of deposition of heterogeneous amyloid beta-peptides and APOE in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3(1):16–32

    Article  PubMed  CAS  Google Scholar 

  • Lippman ME, Dickson RB, Gelmann EP, Rosen N, Knabbe C, Bates S, Bronzert D, Huff K, Kasid A (1988) Growth regulatory peptide production by human breast carcinoma cells. J Steroid Biochem 30:53–61

    Article  PubMed  CAS  Google Scholar 

  • Lue L-F, Rogers J (1992) Full complement activation fails in diffuse plaques of the Alzheimer’s disease cerebellum. Dementia 3:308–313

    Google Scholar 

  • Luine VN (1985) Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89(2):484–490

    Article  PubMed  CAS  Google Scholar 

  • Maeda T, Lloyd RV (1993) Protein kinase C activity and messenger RNA modulation by estrogen in normal and neoplastic rat pituitary tissue. Lab Invest 68:472–480

    PubMed  CAS  Google Scholar 

  • Maizels ET, Miller JB, Cutler RJ, Jackiw V, Carney EM, Mizuno K, Ohno S, Hunzicker DM (1992) Estrogen modulates Ca(2+)-independent lipid-stimulated kinase in the rabbit corpus luteum of pseudopregnancy. Identification of luteal estrogen-modulated lipid-stimulated kinase as protein kinase C delta. J Biol Chem 267:17061–17068

    PubMed  CAS  Google Scholar 

  • Masliah E, Terry RD, Mallory M, Alford M, Hansen LA (1990) Diffuse plaques do not accentuate synapse loss in Alzheimer’s disease. Am J Pathol 137:1293–1297

    PubMed  CAS  Google Scholar 

  • Mayeux R, Gandy S (1999) Cognitive Impairment, Alzheimer’s Disease and Other Dementias. In: Goldman MB, Hatch MC (eds) Women and Health. Academic Press, San Diego CA

    Google Scholar 

  • Miranda RC, Sohrabji F, Toran-Allerand CD (1993) Neuronal colocalization of mRNAs for neurotrophins and their receptors in the developing central nervous system suggests a potential for autocrine interactions. Proc Natl Acad Sci USA 90:6439–6443

    Article  PubMed  CAS  Google Scholar 

  • Miranda RC, Sohrabji F, Toran-Allerand CD (1993) Interactions of estrogen with the neurotrophins and their receptors during neural development. Mol Cell Neurosci 4:510–525

    Article  PubMed  CAS  Google Scholar 

  • Nitsch RM, Slack BE, Wurtman RJ, Growdon JH (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258:304–307

    Article  PubMed  CAS  Google Scholar 

  • Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MD, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA (1998) An essential role for ectodomain shedding in mammalian development. Science 282(5392):1281–1284

    Article  PubMed  CAS  Google Scholar 

  • Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993) Neurodegenera-tion induced by β-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci 13:1676–1687

    PubMed  CAS  Google Scholar 

  • Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinisto L, Halonen P, Kontula K (1995) Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 333(19):1242–1247

    Article  PubMed  CAS  Google Scholar 

  • Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer’s disease: allelic variation and receptor interactions. Neuron 11(4):575–580

    Article  PubMed  CAS  Google Scholar 

  • Refolo LM, Salton SR, Anderson JP, Mehta P, Robakis NK (1989) Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures. Biochem. Biophys. Res Commun 164:664–670

    Article  PubMed  CAS  Google Scholar 

  • Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V (1998) The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophic receptor signalling. Prog Neurobiol 56:541–569

    Article  PubMed  CAS  Google Scholar 

  • Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V (1998) p75 and trkA receptor signalling independently regulate amyloid precursor protein mRNA expression, isoform composition and protein secretion in PC12 cells. J Neurochem 71:757–766

    Article  PubMed  CAS  Google Scholar 

  • Rogers J et al. (1992) Complement activation by β-amyloid in Alzheimer’s disease. Proc. Natl Acad USA 89:10016–10020

    Article  CAS  Google Scholar 

  • Sahasrabudhe SR, Spruyt MA, Muenkel HA, Blume AJ, Vitek MP, Jacobsen JS (1992) Release of amino-terminal fragments from amyloid precursor protein reporter and mutated derivatives in cultured cells. J Biol Chem 267:25062–25608

    Google Scholar 

  • Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joos SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses ADL (1993) Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43:1467–1472

    Article  PubMed  CAS  Google Scholar 

  • Savage MJ, Trusko SP, Howland DS, Pinsker LR, Mistretta S, Reaume AG, Greenberg ND, Siman R, Scott RW (1998) Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. J Neurosci 18(5):1743–1752

    PubMed  CAS  Google Scholar 

  • Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med 2(8):864–870

    Article  PubMed  CAS  Google Scholar 

  • Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin L-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJJ, Wasco W, da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St. George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375:754–760

    Article  PubMed  CAS  Google Scholar 

  • Sinha S, Lieberburg I (1992) Normal metabolism of the amyloid precursor protein (APP). Neurodegeneration 1:169–175

    Google Scholar 

  • Snow AD, Sekiguchi R, Nochlin D, Kimata K, Schreier WA, Morgan DG (1994) An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar Aβ amyloid in rat brain. Neuron 12: 219–234

    Article  PubMed  CAS  Google Scholar 

  • Sohrabji F, Greene LA, Miranda RC, Toran-Allerand CD (1994) Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. J Neurobiol 25(8): 974–988

    Article  PubMed  CAS  Google Scholar 

  • Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Finch CE (1998) Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: Implications for Alzheimer’s disease. J Neurosci 18(9):3180–3185

    PubMed  CAS  Google Scholar 

  • Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Saivesen GS, Roses AD (1993) Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer’s disease. Proc. Natl Acad Sci USA 90:1977–1981

    Article  PubMed  CAS  Google Scholar 

  • Sun Y, Wu S, Bu G, Onifade MK, Patel SN, LaDu MJ, Fagan AM, Holtzman DM (1998) Glial fibrillary acidic protein-apolipoprotein E (APOE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci 18(9):3261–3272

    PubMed  CAS  Google Scholar 

  • Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R (1996) Effect of estrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 348(9025):429–432

    Article  PubMed  CAS  Google Scholar 

  • Wisniewski T, Frangione B (1992) Apolipoprotein E: A pathological chaperone in patients with cerebral and systemic amyloid. Neurosci Lett 135:235–238

    Article  PubMed  CAS  Google Scholar 

  • Woolley CS (1998) Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus. Horm Behav 34(2):140–148

    Article  PubMed  CAS  Google Scholar 

  • Xu H, Gouras GK, Greenfield JP, Vincent B, Naslund J, Mazzarelli L, Fried G, Javanovic JN, Seeger M, Relkin NR, Liao F, Checler F, Buxbaum JD, Chait BT, Thinakaran G, Sisodia SS, Wang R, Greengard P, Gandy S (1998) Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med 4(4):447–451

    Article  PubMed  CAS  Google Scholar 

  • Xu H, Greengard P, Gandy S (1995) Regulated formation of Golgi secretory vesicles containing Alzheimer beta-amyloid precursor protein. J Biol Chem 270(40):23243–23245

    Article  PubMed  CAS  Google Scholar 

  • Yaffe K, Sawaya G, Lieberburg I, Grady D (1998) Estrogen therapy in postmenopausal women. JAMA 279:688–695

    Article  PubMed  CAS  Google Scholar 

  • Yang DS, Small DH, Seydel U, Smith JD, Hallmayer J, Strickland D, Gandy SE, Martins RN Apolipoprotein E promotes the association of amyloid-β with Chinese Hamster Ovary cells in an isoform-specific manner. Neuroscience (in press)

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gandy, S. (2002). Neurohormonal Signalling Pathways and the Regulation of Alzheimer β-Amyloid Metabolism Integrating Basic and Clinical Observations for Developing Successful Strategies to Delay, Retard or Prevent Cerebral Amyloidosis in Alzheimer’s Disease. In: Marcoux, F.W., Choi, D.W. (eds) CNS Neuroprotection. Handbook of Experimental Pharmacology, vol 155. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06274-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-06274-6_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-07625-1

  • Online ISBN: 978-3-662-06274-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics